Why Consider MRI Biomarkers for Clinical Trials in Psychiatric Disorders

Explore how neuroimaging enables researchers to advance beyond traditional symptom-based evaluations toward objective, biologically driven insights.

This eBook explores:

- The urgent need for reliable neurobiological markers in psychiatric disorders

- Leading MRI biomarkers for conditions such as depression, schizophrenia, and bipolar disorder

- The impact of advanced imaging and AI on the reproducibility and data richness of clinical trials

- Real-world examples of how these technologies improve decision-making and accelerate discovery